Nephros wins FDA nod for chronic renal failure device

The FDA has granted Nephros 510(k) clearance for its Hemodiafiltration system, which is used to help treat patients with chronic renal failure. The device features the company's OLpur MD220 Hemodiafilter and OLpur H2H Hemodiafiltration module.

View Full Article in:

Nephros, Inc. Receives 510(k) Clearance for Hemodiafiltration System - Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN